ASG Biochem — Asg Biochem Private Limited
Asg Biochem Private Limited is a Private Non-govt company company incorporated in 2004 and based in Delhi, India. Asg Biochem Private Limited operates in Allopathic pharmaceutical preparations, manufacturing (NIC 24232) with authorized capital of ₹17.00 Cr and paid-up capital of ₹16.40 Cr. For 2022-23, the company reported revenue of ₹33.42 Cr and profit after tax of ₹1.43 Cr. The board has 2 active directors. RegisterKaro's provisional Compliance Health Score for the company is 100/100 (grade A), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
ASG Biochem - Manufacturer of specialized active pharmaceutical ingredients and intermediates for global distribution.
Quick facts
Directors
2 activeMCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 20 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 25 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 24 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Asg Biochem Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 500689405 | Axis Bank Ltd(Bank) | ₹5.22 Cr | 19 Sep 2020 | Open |
| 908527574 | Axis Bank Ltd(Bank) | ₹1.99 Cr | 12 Mar 2022 | Satisfied |
| 243752456 | ICICI Bank Ltd(Bank) | ₹8.13 Cr | 27 Jan 2020 | Open |
| 579982458 | Kotak Mahindra Bank Ltd(Bank) | ₹2.53 Cr | 04 Jul 2019 | Open |
Charge IDs, lenders & amounts for Asg Biochem Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2022-23 | — | ||||
| 2021-22 | — | ||||
| 2020-21 | — | ||||
| 2019-20 | — | ||||
| 2015-16 | — |
Detailed Financials
4 FYs| Line item | 2022-23 | 2021-22 | 2020-21 | 2019-20 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ||||
| Other income | ||||
| Total income | ||||
| Total expenses | ||||
| Profit before tax | ||||
| Profit / (Loss) after tax | ||||
| Balance sheet | ||||
| Equity / Net worth | ||||
| Borrowings | ||||
| Current liabilities | ||||
| Total liabilities | ||||
| Current assets | ||||
| Cash & equivalents | ||||
| Total assets | ||||
| Employees | — | — | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2022-23 | +68.0% | +88.0% | — | |
| Profit after Tax2022-23 | +496.0% | -55.0% | — | |
| Net Worth2022-23 | +59.0% | +43.0% | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2015-16 | -1.97% | — | -10.16% | -2.05% | 4.95 | |||
| 2019-20 | +10.45% | +28.41% | +31.57% | +12.42% | 2.54 | |||
| 2020-21 | +0.76% | -1.05% | +1.40% | +0.56% | — | |||
| 2021-22 | +1.05% | +9.39% | +1.20% | +0.64% | — | |||
| 2022-23 | +4.27% | +34.81% | +4.63% | +3.34% | — |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 2 | 2,55,70,598 | 68.15% |
| Institutional Investors | 1 | 52,65,939 | 14.03% |
| Public & Others | 28 | 66,86,423 | 17.82% |
Promoter, institutional & public holding for Asg Biochem Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
14 peersEvents & timeline
3External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.